- Home
- NVST vs XENE Comparison
NVST vs XENE Comparison
Compare NVST & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVST
- XENE
- Stock Information
- Founded
- NVST 2018
- XENE 1996
- Country
- NVST United States
- XENE Canada
- Employees
- NVST N/A
- XENE N/A
- Industry
- NVST Medical/Dental Instruments
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- NVST Health Care
- XENE Health Care
- Exchange
- NVST Nasdaq
- XENE Nasdaq
- Market Cap
- NVST 3.5B
- XENE 3.0B
- IPO Year
- NVST 2019
- XENE 2014
- Fundamental
- Price
- NVST $21.40
- XENE $40.14
- Analyst Decision
- NVST Hold
- XENE Strong Buy
- Analyst Count
- NVST 13
- XENE 10
- Target Price
- NVST $20.86
- XENE $57.30
- AVG Volume (30 Days)
- NVST 2.3M
- XENE 397.0K
- Earning Date
- NVST 10-30-2024
- XENE 11-12-2024
- Dividend Yield
- NVST N/A
- XENE N/A
- EPS Growth
- NVST N/A
- XENE N/A
- EPS
- NVST N/A
- XENE N/A
- Revenue
- NVST $2,503,300,000.00
- XENE N/A
- Revenue This Year
- NVST N/A
- XENE N/A
- Revenue Next Year
- NVST $2.94
- XENE $1,600.08
- P/E Ratio
- NVST N/A
- XENE N/A
- Revenue Growth
- NVST N/A
- XENE N/A
- 52 Week Low
- NVST $15.15
- XENE $28.20
- 52 Week High
- NVST $25.64
- XENE $50.99
- Technical
- Relative Strength Index (RSI)
- NVST 62.40
- XENE 39.82
- Support Level
- NVST $19.94
- XENE $37.34
- Resistance Level
- NVST $21.49
- XENE $44.61
- Average True Range (ATR)
- NVST 0.68
- XENE 1.71
- MACD
- NVST -0.04
- XENE -0.58
- Stochastic Oscillator
- NVST 74.11
- XENE 22.98
About NVST Envista Holdings Corporation
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments comprising Specialty Products and Technologies and Equipment and Consumables. The Company's Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Company's Equipment & Consumables segment manufactures dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.